Search

Search Constraints

You searched for: Author/Creator Taxonera, C

Search Results

1. DOP004 Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY. (16th January 2018)

2. DOP40 Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-control study. (27th May 2021)

3. DOP44 Efficacy and safety of tacrolimus in ulcerative colitis: a nationwide, multi-centre study from GETECCU. (25th January 2019)

4. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. (17th March 2021)

5. Evolution After Anti‐TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long‐Term Follow‐Up Study. (January 2017)

6. Long‐Term Safety ofIn UteroExposure to Anti‐TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. (March 2018)

8. OP14 Prevention of postoperative recurrence of Crohn's disease with vedolizumab: First results of the prospective placebo-controlled randomised trial REPREVIO. (30th January 2023)

9. OP29 Tofacitinib in ulcerative colitis: Real-world evidence from Eneida Registry. (15th January 2020)

10. P223 Efficacy and safety of tacrolimus in Crohn's disease: a nationwide, multi-centric study from GETECCU. (25th January 2019)